Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meera Mohan

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Ejhaem|July 18, 2022
Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary diseaseAl-Ola Abdallah, Ghulam Rehman Mohyuddin, Nausheen Ahmed, et al.
Blood Cancer Journal|February 25, 2022
Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort studyJing Dong, Zhuping Garacci, Christopher Staffi Buradagunta, et al.
Transplantation and Cellular Therapy|January 22, 2023
Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to DPd-alone for patients with Relapsed Refractory Multiple MyelomaHamza Hashmi, Shebli Atrash, Jayanshu Jain, et al.
European Journal of Haematology|February 8, 2023
Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myelomaAl-Ola Abdallah, Zahra Mahmoudjafari, Nausheen Ahmed, et al.
Blood Advances|February 24, 2026
Plasma cell leukemia: genomic features and their potential relevance for exploring clinical actionabilityMeera Mohan, Natalie Danziger, Othman Salim Akhtar, et al.
Microbiology Resource Announcements|February 8, 2020
Complete Genome Sequences of Four Isolates of Vancomycin-Resistant Enterococcus faecium with the <i>vanA</i> Gene and Two Daptomycin Resistance Mutations, Obtained from Two Inpatients with Prolonged BacteremiaPiroon Jenjaroenpun, Thidathip Wongsurawat, Zulema Udaondo, et al.
Open Forum Infectious Diseases|June 19, 2020
Two Cases of Vancomycin-Resistant <i>Enterococcus faecium</i> Bacteremia With Development of Daptomycin-Resistant Phenotype and its Detection Using Oxford Nanopore SequencingZulema Udaondo, Piroon Jenjaroenpun, Thidathip Wongsurawat, et al.
Microbiology Resource Announcements|April 13, 2019
Draft Genome Sequences of 48 Vancomycin-Resistant Enterococcus faecium Strains Isolated from Inpatients with Bacteremia and Urinary Tract InfectionZulema Udaondo, Thidathip Wongsurawat, Piroon Jenjaroenpun, et al.
Leukemia Research|June 7, 2023
Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysisAgrima Mian, Syed Arsalan Ahmed Naqvi, Ahsan Ayaz, et al.
Blood Advances|December 18, 2025
Plasma Cell Leukemia: Genomic Features and Their Potential Relevance for Exploring Clinical ActionabilityMeera Mohan, Natalie Danziger, Othman Salim Akhtar, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Ejhaem|July 18, 2022
Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary diseaseAl-Ola Abdallah, Ghulam Rehman Mohyuddin, Nausheen Ahmed, et al.
Blood Cancer Journal|February 25, 2022
Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort studyJing Dong, Zhuping Garacci, Christopher Staffi Buradagunta, et al.
Transplantation and Cellular Therapy|January 22, 2023
Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to DPd-alone for patients with Relapsed Refractory Multiple MyelomaHamza Hashmi, Shebli Atrash, Jayanshu Jain, et al.
European Journal of Haematology|February 8, 2023
Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myelomaAl-Ola Abdallah, Zahra Mahmoudjafari, Nausheen Ahmed, et al.
Blood Advances|February 24, 2026
Plasma cell leukemia: genomic features and their potential relevance for exploring clinical actionabilityMeera Mohan, Natalie Danziger, Othman Salim Akhtar, et al.
Microbiology Resource Announcements|February 8, 2020
Complete Genome Sequences of Four Isolates of Vancomycin-Resistant Enterococcus faecium with the <i>vanA</i> Gene and Two Daptomycin Resistance Mutations, Obtained from Two Inpatients with Prolonged BacteremiaPiroon Jenjaroenpun, Thidathip Wongsurawat, Zulema Udaondo, et al.
Open Forum Infectious Diseases|June 19, 2020
Two Cases of Vancomycin-Resistant <i>Enterococcus faecium</i> Bacteremia With Development of Daptomycin-Resistant Phenotype and its Detection Using Oxford Nanopore SequencingZulema Udaondo, Piroon Jenjaroenpun, Thidathip Wongsurawat, et al.
Microbiology Resource Announcements|April 13, 2019
Draft Genome Sequences of 48 Vancomycin-Resistant Enterococcus faecium Strains Isolated from Inpatients with Bacteremia and Urinary Tract InfectionZulema Udaondo, Thidathip Wongsurawat, Piroon Jenjaroenpun, et al.
Leukemia Research|June 7, 2023
Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysisAgrima Mian, Syed Arsalan Ahmed Naqvi, Ahsan Ayaz, et al.
Blood Advances|December 18, 2025
Plasma Cell Leukemia: Genomic Features and Their Potential Relevance for Exploring Clinical ActionabilityMeera Mohan, Natalie Danziger, Othman Salim Akhtar, et al.
Pageof 7